Marksans Pharma has informed that it enclosed press release. Marksans Pharma (Reuters: MARK.BO; Bloomberg: MRKS IN; NSE: MARKSANS; BSE: 524404) announced that its manufacturing facility located at Plot A-1, Phase 1-A, Verna Industrial Estate, Verna, Goa has been approved by Australian TGA for manufacture of pharmaceutical formulations in Solid Dosage Forms of Tablets and hard Capsules for Australian markets. The products will be manufactured at the above facility in Goa India and marketed & distributed in Australian markets through the Company’s subsidiary Nova Pharmaceuticals Australasia.
The above information is a part of company’s filings submitted to BSE.
